TITLE

THE TREATMENT RESPONSE OF HEPATITIS C INFECTED PATIENTS AND ITS ASSOCIATION WITH MUTATIONS IN THE VIRAL PROTEINS E2 AND NSSA

AUTHOR(S)
Meaden, C.; Chan, S.W.; Mills, P.R.; Warnes, T.W.
PUB. DATE
April 2003
SOURCE
Gut;Apr2003 Supplement 1, Vol. 52, pA107
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Interferon resistance in hepatitis C is a major problem. Double-stranded RNA dependent protein kinase (PKR) is a key mediator of the anti-viral effects of IFN. The viral proteins E2 and NS5A bind to and inhibit PKR function in vitro. Mutations in key regions of E2 (PKR-elF2 phosphorylation homology domain-PePHD) and NS5A (PKR binding domain, including the "interferon sensitivity determining region", ISDR) prevent this binding. It is not known whether mutations in PePHD ore associated with treatment response and there is conflicting data for ISDR from different geographical areas. Aim: We wanted to determine whether there was a correlation between the number of mutations in PePHD and the PKR binding domain (including ISDR) and interferon response. Methods: Pre-treatment serum samples from 27 treatment naive patients infected with genotype 3 were analysed by direct sequencing of PePHD and the PKR binding domain. All had received between 3 and 12 months of alpha-interferon at a dose of at least 3 MU 3 times per week. There were 9 sustained responders (SR), 13 transient responders (TR), and 5 non-responders (NR). Results: For PePHD the mean number of mutations was SR = 0.8 (range 0-2), TR = 0.2 (range 0-1) and NR = 0.2 (range 0-1). There was no significant difference in the frequency of mutations, SR vs NR p = 0.31 and SR vs (TR+NR) p = 0.15. For the PKR binding domain, including ISDR the mean number of mutations was SR = 1 (range 0-2), TR = 1.6 (range 0-4), and NR = 0.2 (range 0-2). There was no significant difference in the frequency of mutations, SR vs NR p = 1.0 and SR vs (TR+NR) p = 0.66. There was no significant difference for ISDR alone. Conclusion: The results ore consistent with European studies and differ from Japanese studies. The intrinsically higher frequency of mutant strains in Japanese populations may account for this difference.
ACCESSION #
9748021

 

Related Articles

  • Relationship of Hepatitis C Genotype 1 NS5A Sequence Mutations to Early Phase Viral Kinetics and Interferon Effectiveness. Schiappa, Deborah A.; Mittal, Chetna; Brown, Jennifer A.; Mika, Brian P. // Journal of Infectious Diseases;4/1/2002, Vol. 185 Issue 7, p868 

    The interferon (IFN) sensitivity--determining region (ISDR) of the hepatitis C virus (HCV) NS5A protein is controversially implicated in determining IFN-a--sustained viral response for HCV genotype 1--infected patients. Because the NS5A protein interferes with protein kinase antiviral ...

  • Mutations in the Protein Kinase-Binding Domain of the NS5A Protein in Patients Infected with Hepatitis C Virus Type la Are Associated with Treatment Response. Sarrazin, Christoph; Berg, Thomas; Jung-Hun Lee; Ruster, Brigitte; Kronenberger, Bernd; Roth, W. Kurt; Zeuzem, Stefan // Journal of Infectious Diseases;2/1/2000, Vol. 181 Issue 2, p432 

    Demonstrates an interaction of the hepatitis C virus NS5A protein with the interferon-alpha-inducible double-stranded RNA-activated protein kinase in vitro. Major causes of chronic hepatitis; Use of interferon-alpha in the treatment of hepatitis; Pretreatment amino acid sequences of the NS5A...

  • Genetic Heterogeneity of the NS5A Gene of Hepatitis C Virus and Early Response to Interferon-α. Boulestin, Anne; Sandres-Saune, Karine; Payen, Jean-Louis; Rostaing, Lionel; Pasquier, Christophe; Izopet, Jacques // Journal of Infectious Diseases;11/1/2003, Vol. 188 Issue 9, p1367 

    The double-stranded RNA-activated protein kinase-binding domain (PKRbd) of the NS5A gene of hepatitis C virus (HCV) was studied by the cloning and sequencing method, in HCV-infected patients who had a primary resistance to treatment with interferon (IFN)-α (early nonresponders). Patients...

  • dsRNA-Dependent Protein Kinase PKR and its Role in Stress, Signaling and HCV Infection. Dabo, Stéphanie; Meurs, Eliane F. // Viruses (1999-4915);Nov2012, Vol. 4 Issue 11, p2598 

    The double-stranded RNA-dependent protein kinase PKR plays multiple roles in cells, in response to different stress situations. As a member of the interferon (IFN)-Stimulated Genes, PKR was initially recognized as an actor in the antiviral action of IFN, due to its ability to control...

  • Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes. de Lucas, Susana; Bartolomé, Javier; Carreño, Vicente; Bartolome, Javier; Carreno, Vicente // Journal of Infectious Diseases;1/1/2005, Vol. 191 Issue 1, p93 

    Background: Hepatitis C virus (HCV) proteins interfere with the interferon (IFN)-alpha-induced Jak/signal transducer and activator of transcription (STAT) pathway. Which protein is responsible for this effect and whether this interference results in down-regulation of IFN-induced...

  • Molecular Determinants and Dynamics of Hepatitis C Virus Secretion. Coller, Kelly E.; Heaton, Nicholas S.; Berger, Kristi L.; Cooper, Jacob D.; Saunders, Jessica L.; Randall, Glenn // PLoS Pathogens;Jan2012, Vol. 8 Issue 1, Special section p1 

    The current model of hepatitis C virus (HCV) production involves the assembly of virions on or near the surface of lipid droplets, envelopment at the ER in association with components of VLDL synthesis, and egress via the secretory pathway. However, the cellular requirements for and a...

  • Ribavirin Up-Regulates the Activity of Double-Stranded RNA-Activated Protein Kinase and Enhances the Action of Interferon-α against Hepatitis C Virus. Wei-Liang Liu; Wen-Cheng Su; Ching-Wei Cheng; Lih-Hwa Hwang; Chih-Chiang Wang; Hui-Ling Chen; Ding-Shinn Chen; Ming-Yang Lai // Journal of Infectious Diseases;8/1/2007, Vol. 196 Issue 3, p425 

    Background. Ribavirin's mechanism of action in the treatment of chronic hepatitis C remains to be clarified. Double-stranded RNA-activated protein kinase (PKR) plays a role in cell defense against virus infection. This study investigated whether PKR is a mediator of the effectiveness of...

  • Hepatitis C Virus Controls Interferon Production through PKR Activation. Arnaud, Noëlla; Dabo, Stéphanie; Maillard, Patrick; Budkowska, Agata; Kalliampakou, Katerina I.; Mavromara, Penelope; Garcin, Dominique; Hugon, Jacques; Gatignol, Anne; Akazawa, Daisuke; Wakita, Takaji; Meurs, Eliane F. // PLoS ONE;2010, Vol. 5 Issue 5, p1 

    Hepatitis C virus is a poor inducer of interferon (IFN), although its structured viral RNA can bind the RNA helicase RIG-I, and activate the IFN-induction pathway. Low IFN induction has been attributed to HCV NS3/4A protease-mediated cleavage of the mitochondria-adapter MAVS. Here, we have...

  • The Amino Acid Sequence of the PKR-eIF2alpha Phosphorylation Homology Domain of Hepatitis C Virus... Cochrane, Alexandrad; Orr, Alexander; Shaw, Megan L.; Mills, Peter R.; McCruden, Elizabeth A. B. // Journal of Infectious Diseases;11/1/2000, Vol. 182 Issue 5, p1515 

    Investigates the role of a region of the hepatitis C virus envelope 2 protein, the protein kinase, PKR and early initiation factor 2alpha phosphorylation homology domain (PePHD) in interferon-alpha resistance. Amplification of PePHD via polymerase chain reaction; Obtaining of PePHD amino acid...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics